NCT04306900 2025-07-29TTX-030 in Combination With Immunotherapy and/or Chemotherapy in Subjects With Advanced CancersTrishula Therapeutics, Inc.Phase 1 Completed185 enrolled 28 charts
NCT02887248 2023-12-05Nab-paclitaxel Plus Gemcitabine as First-line Therapy for Cisplatin-ineligible or Cisplatin-incurable Advanced Urothelial CarcinomaSCRI Development Innovations, LLCPhase 2 Terminated3 enrolled 9 charts